Background illustration for clinical trials search

Pulmonary Hypertension Clinical Trials

Browse 652 pulmonary hypertension clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1
Active & Responsive

A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)

for
Pulmonary Arterial Hypertension
Location: New Hyde Park NY, New York NY, Philadelphia PA,
Sponsor: Insmed Incorporated

Sex: All

Age: 18 - 70+

Code: NCT07481981

Phase 3, Recruiting

A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease

for
Pulmonary Hypertension,
Location: Boston MA, New Haven CT, Manhasset NY, New York NY,
Sponsor: Pulnovo Medical, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07214376

Recruiting

A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)

for
Pulmonary Hypertension, Interstitial Lung Disease,
Location: Kissimmee FL, Louisville KY, Bend OR
Sponsor: Pulmovant, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07816185

Phase 3, Recruiting

Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease

for
Asthma, COPD, Interstitial Lung Disease, Cystic Fibrosis,
Location: Kansas City KS
Sponsor: Mario Castro, MD, MPH

Sex: All

Age: 3+

Code: NCT04624490

Phase 1, Recruiting

: Vascular Function in Health and Disease

for
Chronic Obstructive Pulmonary Disease,
Location: Salt Lake City UT
Sponsor: D. Walter Wray

Sex: All

Age: 18+

Code: NCT02966665

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders

for
Adult Congenital Heart Disease, Pulmonary Hypertension,
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 16+

Code: NCT07477197

Recruiting

CVD/PH and Voice Characteristics

for
Pulmonary Hypertension, Cardiovascular Diseases
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT07311044

Recruiting

Prospective Validation of the Novel PVD-B65 Risk Score in Patients With Chronic Lung Disease and Pulmonary Hypertension

for
Chronic Lung Disease, Pulmonary Hypertension
Location: Philadelphia PA
Sponsor: Temple University

Sex: All

Age: 18 - 70+

Code: NCT07151768

Recruiting

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

for
Pulmonary Hypertension Due to Lung Diseases and Hypoxia,
Location: Lebanon NH, New Hyde Park NY, Neptune City NJ,
Sponsor: United Therapeutics

Sex: All

Age: 18+

Code: NCT06388421

Recruiting

Glucocorticoids and Pulmonary Hypertension

for
Pulmonary Hypertension Due to Lung Diseases and Hypoxia,
Location: Saint Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 0 - 5

Code: NCT04499196

Recruiting

Right Ventricle Lipid in Pulmonary Arterial Hypertension (PAH)

for
Idiopathic Pulmonary Arterial Hypertension,
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 18+

Code: NCT05462574

Recruiting

Pulmonary Hypertension Association Registry

for
Pulmonary Arterial Hypertension,
Location: Providence RI, Farmington CT, New York NY,
Sponsor: Pulmonary Hypertension Association, Inc.

Sex: All

Age: 0+

Code: NCT04071327

Recruiting

Xenon MRI Pulm Hypertension

for
Pulmonary Hypertension, Pulmonary Arterial Hypertension
Location: Durham NC
Sponsor: Bastiaan Driehuys

Sex: All

Age: 18 - 70+

Code: NCT04991454

Phase 2, Recruiting

129 Xenon Imaging in Patients Treated With Sotatercept

for
Pulmonary Hypertension, Pulmonary Arterial Hypertension
Location: Durham NC
Sponsor: Bastiaan Driehuys

Sex: All

Age: 18 - 70+

Code: NCT06351345

Phase 2, Recruiting

Hormonal, Metabolic, and Signaling Interactions in PAH

for
Idiopathic Pulmonary Arterial Hypertension,
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 0 - 70+

Code: NCT01884051

Recruiting

Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System

for
Pulmonary Arterial Hypertension, Pulmonary Hypertension,
Location: Boston MA, New York NY, Charleston SC, Columbus OH,
Sponsor: Aria CV, Inc

Sex: All

Age: 18+

Code: NCT04555161

Recruiting

129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)

for
Pulmonary Arterial Hypertension,
Location: Durham NC
Sponsor: Bastiaan Driehuys

Sex: All

Age: 18 - 70+

Code: NCT06104228

Phase 2, Recruiting
New

Rehabilitation Program for People With Methamphetamine-Associated Cardiopulmonary Conditions

for
Methamphetamine-Associated Heart Failure,
Location: Salt Lake City UT
Sponsor: Michael Incze

Sex: All

Age: 18+

Code: NCT07915882

Recruiting
New

A Clinical Trial of NS-863 in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

for
Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD),
Location: Knoxville TN
Sponsor: NS Pharma, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07441278

Phase 2, Recruiting

Chronic Thromboembolic Disease Registry

for
Chronic Thromboembolic Pulmonary Hypertension,
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT05843500

Recruiting

What is pulmonary hypertension?

Pulmonary hypertension is raised blood pressure in the arteries that carry blood from the heart to the lungs. Over time the right side of the heart has to pump harder against that pressure, and it can weaken and fail. Symptoms come on slowly: breathlessness with activity, tiredness, chest pressure, dizziness or fainting, and swelling in the ankles or belly. Because these signs look like asthma, heart disease, or simply being out of shape, the diagnosis is often delayed. It is suspected on an echocardiogram and confirmed by right heart catheterization, which measures the pressure directly.

Doctors sort pulmonary hypertension into five groups by cause, and the group decides the treatment. Group 1 is pulmonary arterial hypertension, or PAH, a rare disease of the small lung arteries themselves, which can be idiopathic, inherited, or linked to conditions such as scleroderma. Group 2, the most common, comes from left sided heart disease; group 3 from lung diseases such as COPD and pulmonary fibrosis; group 4 from old blood clots in the lungs, which surgery can sometimes cure; and group 5 from other or mixed causes. Most PAH medicines are approved only for group 1, which is why most drug trials enroll people with PAH.

Types of pulmonary hypertension clinical trials

Who can participate in pulmonary hypertension clinical trials?

Groups and functional class, and why they matter for trials

How to enroll in a pulmonary hypertension clinical trial